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Reports of the use of hypothermia as a treatment for brain
injury appeared as early as 1943. Fay [1] cooled a series of
patients with severe traumatic brain injury to as low as
28°C for 4–7 days and described outcomes that were, in
his view, better than expected. This and subsequent
reports did describe several deaths related to cooling,
however, presumably as a result of cardiac arrhythmias
and sepsis. During the 1960s and 1970s there was little
enthusiasm for this treatment because of the general
feeling that hypothermia was associated with cardiac
arrhythmias, coagulation disorders, and pneumonia.
In the 1980s, however, several investigators demonstrated
in the laboratory that mild or moderate hypothermia
(32–34°C) was sufficient to cause significant improvement
in neurochemical, histologic, and behavioral outcomes in
both ischemia and brain injury models, suggesting that
beneficial effects could be seen without the side effects
that were believed to be associated with lower tempera-
tures. There was a great resurgence of interest in the clini-
cal application of this treatment to patients with stroke
and traumatic brain injury. Since 1990, numerous clinical
studies have been conducted with the use of mild or mod-
erate hypothermia, primarily in Japan and in the USA.
Preliminary reports published in 1993 on patients with
traumatic brain injury suggested some benefit with the
use of this treatment. In one of the studies [2] hypother-
mia was used in severely injured patients only after con-
ventional means of control of intracranial hypertension
had failed. It was used for as long as 4–5 days and was
associated with an increased incidence of pneumonia. In
two other studies [3,4] hypothermia was induced as soon
as possible after the patient was admitted to the trauma
center and was used for 24 or 48h. In all three studies it
was recognized that rapid rewarming of the patients
would cause a rebound increase in intracranial pressure,
and so gradual rewarming was used.
Most recently, the results of three important clinical trials
were published and a multicenter clinical trial was con-
cluded. Schwab et al [5] used moderate hypothermia in a
series of patients with middle cerebral artery infarction.
The patients were cooled to a core body temperature of
33–34°C for 48–72h, with treatment initiated at a mean of
14h after onset of symptoms. This was not a randomized
clinical trial, but the mortality rate was nearly half that
which might have been expected on the basis of historic
controls. The investigators did note that pneumonia was a
frequent complication and occurred in 40% of their
patients. Cardiac arrhythmias were not encountered.
A second study [6] was a randomized trial that evaluated
the use of mild hypothermia during intracranial aneurysm
surgery. In that study, patients in the experimental group
were cooled to 33.5°C only during the surgery for clipping
of their aneurysm. The study found that, compared with
normothermia patients, more patients with acute sub-
arachnoid hemorrhage in the hypothermia group had good
outcomes and fewer of these patients had neurologic
deficits at the time of discharge. These differences were
not statistically significant, however. There was no appar-
ent benefit of hypothermia for patients who had no preop-
erative subarachnoid hemorrhage. No significant
complications could be attributed to hypothermia as a
result of this brief period of cooling (several hours).
The third study and second randomized trial [7] was the
study of the use of this treatment for patients with severe
traumatic brain injury. In that trial, patients who had an
initial Glasgow Coma Scale score in the range 5–7 had sig-
nificantly improved outcomes at 3 and 6 months after
injury if they were treated with therapeutic moderate
hypothermia compared with the normothermia group. No
benefit was seen for patients who had an initial Glasgow
Coma Scale score of 3 or 4. Patients were cooled to 32°C
for 24h in that study.
Finally, a multicenter prospective randomized trial was
recently completed and publication of the results is
expected early in the year 2000. Briefly, that study foundthat therapeutic moderate hypothermia to 32–33°C for
48h did not lead to significant neurologic improvement for
the group as a whole. There was evidence, however, that a
subgroup of patients who were aged less than 45 years,
were kept normovolemic, and had an initial Glasgow
Coma Scale score in the range 5–8 benefitted.
Mechanisms through which this therapy may benefit at
least subgroups of brain injured patients include a signifi-
cant reduction in excitatory amino acids during the period
of cooling, and sustained suppression of cytokines, partic-
ularly interleukin-1b. Other investigators have identified
stabilization of the blood–brain barrier and a general
reduction in the post-traumatic hypermetabolic state as
other possible beneficial effects of this treatment.
The report of Bernard et al in this issue of Critical Care [8]
is unique in that it critically evaluates the potential side
effects of longer term cooling in patients with severe trau-
matic brain injury. The investigators studied 43 patients
with severe traumatic brain injury who were cooled to
33°C for a mean of 8 days and a range of 2–19 days. As has
previously been noted, these investigators did find that
nosocomial pneumonia was quite common and probably
associated with prolonged cooling. They claim a relatively
low incidence of fatal sepsis, however (5%). The
hypothermia-induced hypokalemia was to be expected
and was recognized and treated appropriately. A side
effect not previously seen with shorter periods of cooling
was thrombocytopenia, and is perhaps the most important
side effect that might be related to prolonged periods of
therapeutic moderate hypothermia. It is important to note,
however, that, as with most of the previous studies, they
did not find that cardiac arrhythmias were associated with
long-term cooling. Because of the relatively small number
of patients enroled in the trial, it is difficult to draw mean-
ingful conclusions regarding the therapeutic efficacy of pro-
longed hypothermic treatment based solely on that study.
This and other reports, and most especially the multicen-
ter trial of therapeutic moderate hypothermia and trau-
matic brain injury, indicate that hypothermia is a
complicated treatment that is not likely to be beneficial
for all patients with stroke, aneurysmal subarachnoid hem-
orrhage, or trauma. The challenge for future investigators
is to identify clearly the select subgroups of patients with
central nervous system injury who would benefit. Careful
analysis of studies to date clearly indicate that subgroups
of these patients will benefit from this treatment, but the
multicenter trial also raised concern that other subgroups,
such as those head injured patients who are hypovolemic,
may actually be harmed by the treatment. Thus, it is pre-
mature to offer this therapy as a standard for treatment of
stroke or traumatic brain injury patients and the protocols
for its use must be carefully worked out, as well as the
subpopulations of patients who are most likely to benefit.
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